Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/195865
Title: Machine Learning Prediction of Comorbid Substance Use Disorders among People with Bipolar Disorder
Author: Oliva, Vincenzo
De Prisco, Michele
Pons Cabrera, Maria Teresa
Guzmán, Pablo
Anmella, Gerard
Hidalgo Mazzei, Diego
Grande, Iria
Fanelli, Giuseppe
Fabbri, Chiara
Serretti, Alessandro
Fornaro, Michele
Iasevoli, Felice
De Bartolomeis, Andrea
Murru, Andrea
Vieta i Pascual, Eduard, 1963-
Fico, Giovanna
Keywords: Alcoholisme
Trastorn bipolar
Cànnabis
Drogoaddicció
Aprenentatge automàtic
Abús de substàncies
Alcoholism
Manic-depressive illness
Cannabis
Drug addiction
Machine learning
Substance abuse
Issue Date: 6-Jul-2022
Publisher: MDPI
Abstract: Substance use disorder (SUD) is a common comorbidity in individuals with bipolar disorder (BD), and it is associated with a severe course of illness, making early identification of the risk factors for SUD in BD warranted. We aimed to identify, through machine-learning models, the factors associated with different types of SUD in BD. We recruited 508 individuals with BD from a specialized unit. Lifetime SUDs were defined according to the DSM criteria. Random forest (RF) models were trained to identify the presence of (i) any (SUD) in the total sample, (ii) alcohol use disorder (AUD) in the total sample, (iii) AUD co-occurrence with at least another SUD in the total sample (AUD+SUD), and (iv) any other SUD among BD patients with AUD. Relevant variables selected by the RFs were considered as independent variables in multiple logistic regressions to predict SUDs, adjusting for relevant covariates. AUD+SUD could be predicted in BD at an individual level with a sensitivity of 75% and a specificity of 75%. The presence of AUD+SUD was positively associated with having hypomania as the first affective episode (OR = 4.34 95% CI = 1.42-13.31), and the presence of hetero-aggressive behavior (OR = 3.15 95% CI = 1.48-6.74). Machine-learning models might be useful instruments to predict the risk of SUD in BD, but their efficacy is limited when considering socio-demographic or clinical factors alone.
Note: Reproducció del document publicat a: https://doi.org/10.3390/jcm11143935
It is part of: Journal of Clinical Medicine, 2022, vol. 11, num. 14, p. 3935
URI: http://hdl.handle.net/2445/195865
Related resource: https://doi.org/10.3390/jcm11143935
ISSN: 2077-0383
Appears in Collections:Articles publicats en revistes (Medicina)
Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer)
Articles publicats en revistes (Institut de Neurociències (UBNeuro))

Files in This Item:
File Description SizeFormat 
724241.pdf794.74 kBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons